Literature DB >> 19847897

Cerebrospinal fluid of brain trauma patients inhibits in vitro neuronal network function via NMDA receptors.

Frauke Otto1, Sebastian Illes, Jessica Opatz, Maurice Laryea, Stephan Theiss, Hans-Peter Hartung, Alfons Schnitzler, Mario Siebler, Marcel Dihné.   

Abstract

Neurological diseases frequently induce pathological changes of cerebrospinal fluid (CSF) that might secondarily influence brain activity, as the CSF-brain barrier is partially permeable. However, functional effects of CSF on neuronal network activity have not been specified to date. Here, we report that CSF specimens from patients with reduced Glasgow Coma Scale values caused by severe traumatic brain injury suppress synchronous activity of in vitro-generated neuronal networks in comparison with controls. We present evidence that underlying mechanisms include increased N-methyl-D-aspartate receptor activity mediated by a CSF fraction containing elevated amino acid concentrations. These proof-of-principle data suggest that determining effects of CSF specimens on neuronal network activity might be of diagnostic value.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19847897     DOI: 10.1002/ana.21808

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  8 in total

1.  A new role for interferon gamma in neural stem/precursor cell dysregulation.

Authors:  Janine Walter; Silke D Honsek; Sebastian Illes; Jennifer M Wellen; Hans-Peter Hartung; Christine R Rose; Marcel Dihné
Journal:  Mol Neurodegener       Date:  2011-03-03       Impact factor: 14.195

2.  Human Cerebrospinal fluid promotes long-term neuronal viability and network function in human neocortical organotypic brain slice cultures.

Authors:  Niklas Schwarz; Ulrike B S Hedrich; Hannah Schwarz; Harshad P A; Nele Dammeier; Eva Auffenberg; Francesco Bedogni; Jürgen B Honegger; Holger Lerche; Thomas V Wuttke; Henner Koch
Journal:  Sci Rep       Date:  2017-09-25       Impact factor: 4.379

3.  Human Cerebrospinal Fluid Promotes Neuronal Circuit Maturation of Human Induced Pluripotent Stem Cell-Derived 3D Neural Aggregates.

Authors:  Julia Izsak; Henrik Seth; Stephan Theiss; Eric Hanse; Sebastian Illes
Journal:  Stem Cell Reports       Date:  2020-06-09       Impact factor: 7.765

4.  In vitro neuronal network activity as a new functional diagnostic system to detect effects of Cerebrospinal fluid from autoimmune encephalitis patients.

Authors:  Henner Koch; Cristina E Niturad; Stephan Theiss; Christian G Bien; Christian Elger; Klaus-Peter Wandinger; Angela Vincent; Michael Malter; Peter Körtvelyessy; Holger Lerche; Marcel Dihné
Journal:  Sci Rep       Date:  2019-04-03       Impact factor: 4.379

5.  In vitro neuronal network activity in NMDA receptor encephalitis.

Authors:  Sabine U Jantzen; Stefano Ferrea; Claudia Wach; Kim Quasthoff; Sebastian Illes; Dag Scherfeld; Hans-Peter Hartung; Rüdiger J Seitz; Marcel Dihné
Journal:  BMC Neurosci       Date:  2013-02-05       Impact factor: 3.288

6.  Healthy human CSF promotes glial differentiation of hESC-derived neural cells while retaining spontaneous activity in existing neuronal networks.

Authors:  Heikki Kiiski; Riikka Aänismaa; Jyrki Tenhunen; Sanna Hagman; Laura Ylä-Outinen; Antti Aho; Arvi Yli-Hankala; Stepani Bendel; Heli Skottman; Susanna Narkilahti
Journal:  Biol Open       Date:  2013-05-13       Impact factor: 2.422

7.  Human Cerebrospinal Fluid Promotes Neuronal Viability and Activity of Hippocampal Neuronal Circuits In Vitro.

Authors:  Marta Perez-Alcazar; Georgia Culley; Tim Lyckenvik; Kristoffer Mobarrez; Andreas Bjorefeldt; Pontus Wasling; Henrik Seth; Frederik Asztely; Andrea Harrer; Bernhard Iglseder; Ludwig Aigner; Eric Hanse; Sebastian Illes
Journal:  Front Cell Neurosci       Date:  2016-03-04       Impact factor: 5.505

Review 8.  Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies.

Authors:  Andreas Bjorefeldt; Sebastian Illes; Henrik Zetterberg; Eric Hanse
Journal:  Front Neural Circuits       Date:  2018-02-05       Impact factor: 3.492

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.